Tonix Pharmaceuticals (TNXP)

Add to Watchlists
Create an Alert
2.68 -0.02  -0.74% NASDAQ Apr 28, 22:00 Delayed 2m USD
View Full Chart
TNXP Price Chart
View All Performance Charts

TNXP Total Returns Comparison

Advertisement

One Page Reports

Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • URL: http://www.tonixpharma.com
  • Investor Relations URL: http://ir.tonixpharma.com/
  • HQ Country: United States
  • HQ State/Province: New York
  • Incorporation Country: United States
  • Incorporation State/Province: Nevada
  • Est. Current Fiscal Quarter End: June 30, 2016
  • Est. Current Fiscal Year End: December 31, 2016
  • Last Fiscal Quarter End: December 31, 2015
  • Last Fiscal Year End: December 31, 2015
  • Next Earnings Release: N/A
  • NAICS Name: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry Name: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector Name: Manufacturing
  • Profile: Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company. The Company is engaged in development of next-generation medicines. Its drug development programs are directed toward disorders affecting the central nervous system.

TNXP Comparables

Edit

TNXP Excel Add-In Codes

  • Name: =YCI("TNXP","name")
  • Description: =YCI("TNXP","description")
  • Sector: =YCI("TNXP","sector")
  • Industry: =YCI("TNXP","industry")
  • Est. Current Fiscal Year End: =YCI("TNXP","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.